Table 1.
Baseline characteristics
| nonHDLc/HDLc | Q1 | Q2 | Q3 | P-value |
|---|---|---|---|---|
| Number | 5324 | 5412 | 5437 | |
| Age (years) | 42.5 ± 14.8 | 43.1 ± 14.9 | 44.1 ± 15.1 | <0.001 |
| BMI | 20.6 ± 2.0 | 21.4 ± 2.0 | 22.1 ± 1.9 | <0.001 |
| ALT | 17.8 ± 17.9 | 19.4 ± 13.6 | 22.9 ± 17.3 | <0.001 |
| AST | 22.4 ± 10.1 | 22.7 ± 8.7 | 24.0 ± 9.7 | <0.001 |
| Albumin | 44.3 ± 2.8 | 44.4 ± 2.7 | 44.6 ± 2.6 | <0.001 |
| BUN | 4.5 ± 1.4 | 4.6 ± 1.3 | 4.8 ± 1.4 | <0.001 |
| Cr | 75.5 ± 26.3 | 78.9 ± 22.5 | 81.0 ± 27.7 | <0.001 |
| UA | 249.6 ± 78.4 | 279.2 ± 82.9 | 310.0 ± 85.4 | <0.001 |
| FPG | 5.0 ± 0.7 | 5.1 ± 0.8 | 5.3 ± 0.9 | <0.001 |
| TC | 4.3 ± 0.7 | 4.6 ± 0.7 | 4.9 ± 0.7 | <0.001 |
| TG | 0.9 ± 0.4 | 1.2 ± 0.5 | 1.8 ± 1.3 | <0.001 |
| HDLc | 1.8 ± 0.3 | 1.5 ± 0.2 | 1.1 ± 0.2 | <0.001 |
| LDLc | 2.0 ± 0.4 | 2.3 ± 0.4 | 2.5 ± 0.4 | <0.001 |
| nonHDLc | 2.6 ± 0.5 | 3.2 ± 0.5 | 3.7 ± 0.6 | <0.001 |
| SBP | 117.1 ± 16.4 | 120.7 ± 16.5 | 124.2 ± 16.5 | <0.001 |
| DBP | 70.6 ± 9.9 | 72.7 ± 10.2 | 75.0 ± 10.5 | <0.001 |
| Sex (n, %) | <0.001 | |||
| Male | 2670 (50.2%) | 2580 (47.7%) | 2440 (44.9%) | |
| Female | 2654 (49.8%) | 2832 (52.3%) | 2997 (55.1%) | |
| NAFLD (n, %) | <0.001 | |||
| None | 5043 (94.7%) | 4740 (87.6%) | 4068 (74.8%) | |
| Yes | 281 (5.3%) | 672 (12.4%) | 1369 (25.2%) |
ALT, alanine aminotransferase; SBP, Systolic blood pressure; AST, BUN, TC, total cholesterol; blood urea nitrogen; BMI, body mass index; FPG, fasting plasma glucose; aspartate aminotransferase; TG, triglycerides; UA, uric acid; HDLc, high-density lipoprotein cholesterol; DBP, diastolic blood pressure; LDLc, low-density lipoprotein cholesterol; NAFLD, Cr, creatinine; non-alcoholic fatty liver disease. Values are presented as number (%) or mean ± standard deviation, U/L, mmol/L, kg/m2, umol/L, and mmHg.